Literature DB >> 6834272

Central and peripheral effects of clonidine on the adrenal medullary function in spontaneously hypertensive rats.

H Togashi.   

Abstract

The sites of action of clonidine-induced adrenal suppressant effect were investigated in spontaneously hypertensive rats. For analysis of the adrenal medullary function, efferent adrenal nerve discharges and adrenal venous catecholamine secretion rates were determined. Five to 10 min after i.v. administration of clonidine (3-100 micrograms/kg), there was a decrease in both sympathetic adrenal nerve activity and adrenal catecholamine secretion rates along with the decrease in arterial blood pressure and heart rate. After acute splanchnicotomy, clonidine (50 micrograms/kg i.v.) produced a significant decrease in catecholamine secretion rates from the denervated adrenal medulla during electrical stimulation of the splanchnic nerve. Furthermore, i.c.v. administration of clonidine (1-10 micrograms) decreased adrenal nerve activity. These findings indicate that both the adrenal medulla and the spinal clonidine-induced adrenal suppressant effect. The fact that the clonidine-induced decrease in adrenal catecholamine secretion rates was approximately parallel to the decrease in preganglionic adrenal nerve discharges in nerve intact spontaneously hypertensive rats suggests that the central action of clonidine is important in the adrenal suppressant effect relative to its peripheral action.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6834272

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Effects of intracerebroventricular injection of histamine and related compounds on corticosterone release in rats.

Authors:  S Tsujimoto; Y Okumura; C Kamei; K Tasaka
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

2.  The measurement of norepinephrine clearance and spillover rate into plasma in conscious spontaneously hypertensive rats.

Authors:  T K Keeton; A M Biediger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

3.  Inhibition of uptake 1 by (+)-oxaprotiline reveals a differential central regulation of noradrenaline and adrenaline release.

Authors:  B Szabo; T Auberle; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-09       Impact factor: 3.000

4.  A study of the action of clonidine on secretion from the adrenal medulla in dogs.

Authors:  F Anglade; L Dang Tran; G De Saint Blanquat; G Gaillard; C Michel-Damase; J L Montastruc; P Montastruc; M Rostin; M A Tran
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

5.  A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist.

Authors:  P Ernsberger; M A Haxhiu; L M Graff; L A Collins; I Dreshaj; D L Grove; M E Graves; S G Schäfer; M O Christen
Journal:  Cardiovasc Drugs Ther       Date:  1994-03       Impact factor: 3.727

6.  The Influence of Xylazine and Clonidine on Lung Ultrasound-Induced Pulmonary Capillary Hemorrhage in Spontaneously Hypertensive Rats.

Authors:  Douglas L Miller; Chunyan Dou; Krishnan Raghavendran; Zhihong Dong
Journal:  Ultrasound Med Biol       Date:  2021-05-07       Impact factor: 3.694

7.  Effect of Clonidine (an antihypertensive drug) treatment on oxidative stress markers in the heart of spontaneously hypertensive rats.

Authors:  Nik Syamimi Nik Yusoff; Zulkarnain Mustapha; Chandran Govindasamy; K N S Sirajudeen
Journal:  Oxid Med Cell Longev       Date:  2013-05-16       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.